You are here: Home1 / News
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-05-01 15:09:162026-05-01 15:13:54Risk factors of secondary malignancies in PV
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-26 16:58:062026-04-26 17:01:37Challenges diagnosing MPNs with low JAK2V617F allelic burden
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-23 08:45:592026-04-23 08:45:59How MPNs evolve on therapy
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-15 22:53:292026-04-15 23:09:49Paradigm shift in PV treatment?
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-12 21:28:572026-04-12 21:28:57MPN-FIT: an exercise study specific to MPN patients
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-04 21:54:012026-04-04 21:54:01Jak inhibitor selection in challenging MF scenarios
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-03 20:04:192026-04-03 20:48:05Ruxolitinib treatment in myelofibrosis with anaemia
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-01 13:20:052026-04-03 19:59:42MPN AA grant launches breakthrough Australian discovery
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-04-01 07:55:422026-04-03 20:52:37Fedratinib (Inrebic) listed on the PBS
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png
430
430
Jenny
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg
Jenny2026-03-31 16:01:432026-03-31 16:01:43Prefibrotic myelofibrosis: recent updates 2026
